Next Article in Journal
Characteristics of Gut Microbiota in Patients with Hypertension and/or Hyperlipidemia: A Cross-Sectional Study on Rural Residents in Xinxiang County, Henan Province
Next Article in Special Issue
Performance of an Immunochromatographic Test (ICT) in Comparison to Some Commonly Used Serological Tests for the Diagnosis of Brucellosis in Dromedary Camels (Camelus dromedarius)
Previous Article in Journal
Myxozoan Adhesion and Virulence: Ceratonova shasta on the Move
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Whole Genome Sequencing for Tracing Geographical Origin of Imported Cases of Human Brucellosis in Sweden

1
National and OIE Reference Laboratory for Brucellosis, Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, 64100 Teramo, Italy
2
Department of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden
*
Author to whom correspondence should be addressed.
Microorganisms 2019, 7(10), 398; https://doi.org/10.3390/microorganisms7100398
Submission received: 27 August 2019 / Revised: 23 September 2019 / Accepted: 24 September 2019 / Published: 26 September 2019
(This article belongs to the Special Issue Epidemiology of Zoonotic Diseases)

Abstract

:
Human infections with Brucella melitensis are occasionally reported in Sweden, despite the fact that the national flocks of sheep and goats are officially free from brucellosis. The aim of our study was to analyze 103 isolates of B. melitensis collected from patients in Sweden between 1994 and 2016 and determine their putative geographic origin using whole genome sequencing (WGS)-based tools. The majority of the strains were assigned to East Mediterranean and African lineages. Both in silico Multiple Loci VNTR (Variable Number of Tandem Repeats) Analysis (MLVA) and core genome Multilocus Sequence Typing (cgMLST) analyses identified countries of the Middle East as the most probable source of origin of the majority of the strains. Isolates collected from patients with travel history to Iraq or Syria were often associated with genotypes from Turkey, as the cgMLST profiles from these countries clustered together. Sixty strains were located within a distance of 20 core genes to related genotypes from the publicly available database, and for eighteen isolates, the closest genotype was different by more than 50 loci. Our study showed that WGS based tools are effective in tracing back the geographic origin of infection of patients with unknown travel status, provided that public sequences from the location of the source are available.

1. Introduction

Brucellosis is one of the most widespread bacterial zoonosis globally. Annually, half a million cases of human brucellosis are reported worldwide, but the actual number of cases is estimated to be ten times higher [1,2]. Majority of human cases are caused by Brucella melitensis, which is most frequently transmitted through direct contact with infected goats and sheep and through consumption of unpasteurized milk and dairy products contaminated with the bacteria [3,4,5].
Although the mortality rate of brucellosis is low, it is often debilitating and difficult to diagnose as its clinical presentation may mimic variety of infectious and noninfectious illnesses [6]. The disease can affect any organ system, and the most frequently reported symptoms include pyrexia, arthritis, and fatigue. Unspecific clinical presentation and thus the failure of correct primary diagnosis and treatment often leads to disease progression with genitourinary, neurological, pulmonary, or cardiovascular system involvement, with endocarditis being the most serious of the complications [4,6,7]. Therefore, for a prompt diagnosis, particular attention should be given to the patient’s history of travel to brucellosis endemic areas and consumption of raw milk products.
Ovine and caprine brucellosis has been eradicated in majority of the countries in European Union (EU). A few notable exceptions include Greece, Italy, Spain, and Portugal, where the annual number of confirmed human infections is the highest [8]. In 2017, ~65% of brucellosis cases reported in EU were acquired in Europe, whereas 12% were imported from other countries. Of the latter, the most common travel destinations were Iraq, Turkey, and Syria [8]. Interestingly, the country of infection or travel status was unknown for over 22% of all notified cases. Although in Europe the number of B. melitensis positive flocks in recent years has been gradually decreasing, in the countries of the Middle East, Central Asia, and Africa, the disease is still on the rise [1,9,10]. Therefore, international immigration trends and travel to these regions along with consumption of local contaminated foods and illegal import of dairy products pose a risk of brucellosis infection and augment the number of cases reported in EU [11,12]. Continuous surveillance programs vital for tracing the origin of human infections exist in Europe but they largely rely on effective molecular typing procedures as well as on the availability of good quality, accurate data collected nationally and internationally [13,14,15].
Both traditional and modern typing methods are used in epidemiology of Brucella. Biotyping currently recommended by World Organisation for Animal Health (OIE), divides B. melitensis into three biovars and relies on serological reactions of the main surface antigens with monospecific sera. The method is laborious and requires live bacteria handling and the results are often insufficient for epidemiological purposes. Therefore, molecular methods such as Multilocus Sequence Typing (MLST), Multiple Loci VNTR (Variable Number of Tandem Repeats) Analysis (MLVA), and more recently, whole genome sequencing (WGS) typing methods are additionally used to discriminate between B. melitensis strains, provide higher resolution genetic clustering, and identify outbreak cases [14,16,17,18].
In our work, we sequenced 103 B. melitensis isolates collected in Sweden in the period between 1994 and 2016. The aim of our study was to identify the putative geographic origins of the strains isolated from Swedish patients with unknown history of travel to endemic areas using three different typing methods based solely on WGS analysis.

2. Materials and Methods

2.1. Bacterial Strains and Growth Conditions

The B. melitensis isolates were collected between 1994 and 2016 from Swedish patients that had returned from Brucella endemic countries, stored at the biorepository of the Public Health Agency of Sweden, and used as stipulated in the regulations for diagnostic development and quality assessment. All the B. melitensis human clinical strains were isolated in the BSL-3 laboratory by cultivation of samples on 5% sheep blood agar plates in a 5–10% CO2 atmosphere at 37 °C for 48 h. The isolates used in this study were confirmed as B. melitensis by general real-time PCR that amplifies DNA of all Brucella strains and a specific real-time PCR for B. melitensis, as well as by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS), as previously described [19,20,21].

2.2. Whole Genome Sequencing

Bacterial DNA was extracted using the commercially available EZ1® DNA Tissue Kit from Qiagen, Stockholm, Sweden, according to the manufacturer’s instructions and stored at 4 °C until use. As a process control of an extraction step, 5 µL of seal herpes virus cell culture was spiked in a total volume of 200 µL of each sample. The samples were eluted in 50 µL of elution buffer.
Total genomic DNA extracted from bacterial colonies was quantified with the Qubit fluorometer (QubitTM DNA HS assay; Life Technologies, Thermo Fisher Scientific Inc., Waltham, MA, USA). Sequencing libraries were prepared using Nextera XT library preparation kit (Illumina Inc., San Diego, CA, USA) according to the manufacturer’s instructions. The libraries were sequenced using the Illumina NextSeq 500 platform, producing 150-bp paired-end reads. After demultiplexing and removal of adapters, reads were trimmed from 5′ and 3′ ends using Trimmomatic tool version 0.36 to discard the nucleotides with quality scores of less than 25. Reads shorter than 36 bp were automatically discarded. Scaffolds were assembled with SPAdes version 3.11.1 with the careful option selected [22].
Read sequences were submitted to Sequence Read Archive of the National Center for Biotechnology Information (NCBI) under the BioProject accession number PRJNA551091.

2.3. In Silico MLVA Typing

We extracted the MLVA-16 profiles directly from genome assemblies using MLVA In Silico Typing Resource for Salmonella Strains (MISTReSS, https://github.com/Papos92/MISTReSS#mistress-mlva-in-silico-typing-resource-for-salmonella-strains). MISTReSS tool was customized for extraction of Brucella MLVA-16 panel using previously described set of primers [23] with one modification. In order to avoid multiple primer binding sites, we extended the sequence of the forward primer of Bruce21 locus to 52 bp (5′-GGCAGTGGGGCAGTGAAGAATATGGTCGCTGCGCTCATGCGCAACCAAAACA-3′). Extracted profiles were then loaded and clustered with MLVA-8 and MLVA-16 panels in Bionumerics 7.6.3 (Applied Maths NV, Sint-Martens-Latem, Belgium) using MST (Minimum Spanning Tree) method. Additional 2535 B. melitensis profiles from the public and private MLVA repositories were used for identifying related genotypes.

2.4. MLST and cgMLST Analysis

Genome assemblies produced in our study, along with 139 public genomes available at GenBank (with known geographical origin; accessed on 30 November 2018), were genotyped using cgMLST. The cgMLST profiles were assigned using B. melitensis task template with 2704 target core genes in Ridom SeqSphere+ software, v4.1.1 (Ridom GmbH, Münster, Germany) as described by Janowicz and colleagues (2018) [18]. Multiple spanning tree (MST) was generated by pairwise comparison of cgMLST target genes using default parameters. Missing values were ignored in the calculation of distance between pairs of sample profiles. All sequences were additionally typed using the Brucella 9 locus Multilocus Sequence Typing (MLST-9) scheme available at https://pubmlst.org/brucella/ [24] accessible through Ridom SeqSphere+. Complete MLST-9 allele profiles of B. melitensis strains available in the public database and containing information about geographic origin of the strain (n = 179) were downloaded from https://pubmlst.org/brucella/ (accessed on 22 May 2019). MLST-9 profiles were analyzed using the goeBURST algorithm implemented in PHYLOViZ, version 2.0 [25]. Minimum spanning trees (MST) were created using default software settings.

3. Results

Out of 103 B. melitensis strains isolated from patients in Sweden between years 1994 and 2016, 71 had no available information about the country where the infection was contracted (Table 1). The majority of samples (n = 85) belonged to biovar 3, whereas fifteen were classified as biovar 2 and only three as biovar 1. Biotyping however, was not sufficient to determine the plausible geographic origin of the strains. Interestingly, patients who had traveled to Iraq acquired either one of the biovars.
Using WGS assemblies, we were able to determine MLST profiles for all sequenced genomes. The MLST-9 typing scheme divided the Swedish B. melitensis isolates into five sequence types (ST-7, ST-8, ST-11, ST-12, and ST-71). We retrieved publicly available MLST-9 profiles of B. melitensis samples that included complete “country” information (n = 179). The results of MST clustering are shown in Figure 1. The largest cluster, ST-8, contained 83 of the Swedish isolates, 55 of which with unknown geographic origin. It was, however, impossible to determine the geographic links of ST-8 as it clustered strains from European, Asian, and African countries. Similarly, ST-7 and ST-11 contained isolates from more than one continent. Sequence type 12 was the second largest group and consisted of samples collected mainly in Africa, including two isolated from Swedish patients with travel history to Somalia and Ethiopia. ST-71 was present in Afghanistan.
The MISTReSS tool could recover the VNTRs for the 103 B. melitensis analyzed; however, 43 isolates were missing at least one allele calling. Bruce 43 was absent for 31 isolates and other VNTR null calls were also found for Bruce 06, Bruce 42, Bruce 19, Bruce21, Bruce 07, Bruce 09, Bruce 16, and Bruce 30. Allele 2 of Bruce 06 locus, which was present in only few publicly available B. melitensis MLVA profiles, was identified in sixteen strains from our dataset. Considering that MLVA-8 genotype was complete for 68 of the 103 Swedish isolates, the MST from the MLVA-8 panel was used to assign twenty different genotypes for these isolates (Figure 2). The majority of the profiles were clustered within the East Mediterranean lineage; sixteen belonged to African lineage and two were found in the West Mediterranean clade. Fifty-six isolates, all with complete MLVA-8 profiles, belonged to eight known genotypes (Figure 2), most of which (n = 45) were genotype 42 (GT42). Despite the incompleteness of MLVA-16 profiles, they were clustered with MST to determine the plausible geographic origin of the strains by identifying the closest genotype with known provenance (Table 1). Out of 32 isolates with known origin of infection, thirteen were linked to China according to MLVA-16 typing. Additional 26 Swedish B. melitensis strains of unknown provenance were also predicted to originate in China, the majority with less than three loci distance from the nearest publicly available genotype. Several strains were placed within Saudi Arabia/China/Turkey/Belgium and India/Turkmenistan/China clusters. These genetic links were not exact, as at least one VNTR of difference was observed between profiles of the Swedish isolates and the publicly available profiles. We were only able find identical MLVA-16 profiles for two strains from our study, and these were isolated in Iraq. One strain from patient that likely contracted brucellosis in Somalia was not traced back to African lineage (Table 1).
A comparison of core genome profiles of our set of samples with the publicly available genome assemblies confirmed that majority of the strains isolated in Sweden belonged to the Eastern Mediterranean clade and clustered in close proximity to B. melitensis genomes collected in countries of the Middle East (Figure 3). However, unlike MLVA-8 typing, cgMLST placed thirteen genotypes within African lineage and three in American. Two were clustered within West Mediterranean lineage in accordance with MLVA-8. To find the putative country of origin of the strains in our dataset, we identified the closest cgMLST genotype with known provenance (Table 1). More than a half of the isolates were located twenty or less loci away from such genomes and for sixteen strains of unknown origin we identified at least one neighbor within previously established 6-loci threshold estimated for a putative outbreak cluster (Table 1). Interestingly, we found that several genetically related strains were isolated in Turkey, Syria, and Iraq or obtained from patients with a travel history to these countries suggesting likely exchange of infected animals or contaminated milk products between these regions.
Seventeen putative outbreak clusters defined by single linkage distance of six gene variants and containing at least three isolates were identified in the cgMLST dataset, out of which, eleven contained at least one strain isolated in Sweden. We found not only that closely related strains could originate from different countries, but additionally some of them persisted in animal populations for long time periods. For instance, in Complex 2, sample 2017-TE-24378-1-12 was collected in 1998 and four other strains were isolated in 2011 and 2015. On the contrary, some complexes, e.g., Complex 12, included several strains genetically related to a Somalian isolate, which were all collected in the same year and possibly originated in the same location.
The isolate 2017-TE-24378-1-90, from a patient with a history of travel to Iraq, was found within American clade. We compared the cgMLST profile of this isolate with a Rev.1 vaccine strain (GCA_002953595.1), which also belongs to the American lineage, and found only two loci of difference between the two profiles confirming that the infection was caused by the vaccine strain (Figure 3).

4. Discussion

In Europe, brucellosis has often been considered a zoonosis affecting mainly veterinarians and livestock owners and breeders. However, increased tourism, migration, and emerging trends towards the consumption of local and raw products have led to changes in epidemiology of human brucellosis and raised the necessity for enhanced surveillance and control programs worldwide.
Most European Union member states, including Sweden, are currently classified as officially free from B. melitensis infection and therefore human brucellosis is considered an imported disease [8]. From epidemiological point of view, it is therefore necessary to trace back the origin of the infection, particularly in cases where history of travel to Brucella endemic regions is unknown.
Our study used WGS based tools combined with associated publicly available databases to determine possible geographic origins of B. melitensis isolates cultured from patients in Sweden. We found that majority of strains belonged to East Mediterranean and African clades. Only five cases were attributed to West Mediterranean and American lineages. The isolates most frequently originated in Middle East and were genetically related to strains from Iraq, Syria, and Turkey in particular. Within the African clade, we found that Somalia was the most likely place where the patients contracted brucellosis. This observation is supported by the demographic composition in Sweden, where Iraqi, Syrians, and Somalians are among the ten largest groups of foreign-born persons, and both new immigrants and travelers visiting their families in these territories likely augment the numbers of cases of brucellosis in Sweden. Other studies have reported similar results, demonstrating that human B. melitensis infection diagnosed in Europe is most frequently acquired in countries of the Middle East, where ovine and caprine brucellosis is endemic [26,27,28,29,30]. The majority of our samples were assigned to the biovar 3, which has been reported to be a predominant B. melitensis biovar isolated from animals and humans in Middle East [27,29,30]. We additionally observed that two closely related isolates, one of which originating in Turkey, belonged to two different biovars. Traditional typing methods are laborious, require skilled technical staff, and good quality reagents and are more prone to erroneous or inconclusive results than molecular typing techniques. The procedure can therefore inadvertently lead to the assignment of a wrong biovar. Moreover, it has been demonstrated that traditional biotyping results may not strictly reflect genetic nor phylogeographic clustering of B. melitensis [31]. Thus, higher resolution molecular typing techniques are now preferentially used for epidemiological studies of Brucella.
Several typing methods can be utilized in molecular epidemiology of brucellosis and our study compared the effectiveness of MLST, MLVA in silico and cgMLST in identifying putative geographic source of B. melitensis strains based on the genetic profile similarities. We found that MLST had little discriminatory power; however, it was still superior to the standard biotyping technique, particularly for identification of the strains likely originating in Africa. MLST has been previously used to describe genetic diversity of Brucella in Asia [32,33], however this method might be more appropriate for deeper phylogenetic points, such as distinction between the species rather than provenance of specific genotypes [34].
The MISTReSS tool could not recover all Variable Number of Tandem Repeats (VNTRs) creating possible genotyping errors especially considering the clusters generated with the smaller MLVA-8 panel that included the set of more stable genetic markers. The probable clustering errors were reduced by using the wider MLVA-16 panel. For majority of the isolates, MLVA-16 assigned the putative origin of the Swedish B. melitensis strains to China or to East Mediterranean clusters that included strains isolated in China and several other countries. Links to Chinese B. melitensis isolates were also observed for strains obtained from patients with known travel history to Middle East. This suggests that MLVA might not have enough resolution to discern between some strains of East Mediterranean lineage or that the public collection of MLVA profiles is insufficient to find some of the truly related strains. Indeed, we were only able to identify two exact MLVA-16 profile matches to our isolates in the public database.
Gene-by-gene analysis of genome assemblies and comparison of the cgMLST profiles allowed identification of at least one neighboring isolate with known geographic origin located within a distance of six alleles for sixteen of the strains from Swedish patients. This would suggest a high probability that these strains originated from the same region. Interestingly, we found that very closely related strains were often isolated from travelers returning from Turkey, Syria, and Iraq. As the three countries share their borders, people may travel through more than one of the brucellosis endemic regions to reach their destination. Moreover, it is likely that the infected animals or contaminated products are often exchanged between the bordering territories. Indeed, in recent years, due to human migration from Syria, an estimated 100,000 of sheep and goats were introduced to Northern provinces of Iraq [35]. Illegal animal movements undermine national brucellosis control programs and are a serious risk for public health, particularly where unpasteurized dairy products are frequently consumed.
Using WGS analysis, we were able to identify a likely case of infection with B. melitensis Rev-1 vaccine strain that had been previously demonstrated to be pathogenic in human [36]. Sheep vaccination against B. melitensis is recommended in Iraq and several mass vaccination campaigns were undertaken in the past [37]. The patient with the history of travel to Iraq must have, therefore, acquired the infection from the vaccinated animals or their products. The live attenuated Rev.1 strain is widely used to control brucellosis in small ruminants and, when properly administered, it provides long lasting protection against disease. However, in pregnant animals, the bacteria can still be shed in milk and thus consuming unpasteurized milk and dairy products from recently immunized animals poses a high risk of infection [36]. Additionally, WGS analysis suggested a link between two isolates which shared the same cgMLST profile, one from a returning traveler to Iraq and a person with no travel history to brucellosis endemic areas. Further inquiry revealed that the infection acquired in Sweden was a healthcare worker who got infected while processing the sample from the other patient [38].
Molecular typing methods are essential in control and surveillance of infectious diseases. Here, we showed the utility of WGS-based tools, but currently their use requires specialized personnel and equipment for genome sequencing and bioinformatic analyses that may be limited to larger institutes and to reference centers. Traditional MLVA, available in many of laboratories, might therefore still be used as a first line assay, as it offers sufficient discriminatory power for the routine brucellosis surveillance programs [14,16,39].
Despite the superior resolution of cgMLST compared to the other tools used in our study, we did not find closely related strains to at least eighteen isolates which differed from the other strains by at least 50 target genes. This highlights the limitations imposed by the lack of publicly available sequences from B. melitensis endemic regions. In fact, a large proportion of deposited data are obtained from human infections imported from abroad and in many cases the epidemiological data, such as host, year and location of pathogen isolation are missing. Moreover, for human isolates where the strain isolation country is known, it might not coincide with the location where the infection was contracted. Additionally, the sequences of B. melitensis strains isolated from small ruminants are lacking, partially due to lack of resources for application of WGS technology in developing countries and, secondly, due to a lesser impact of animal infection epidemiology compared to human brucellosis research. In order to facilitate programs for effective control and surveillance of brucellosis worldwide an international effort should be made to provide sufficient data for effective tracing of B. melitensis in the world and in particular in the regions where ovine and caprine brucellosis is currently endemic or re-emerging.

Author Contributions

Conceptualization, G.G. and A.J.; Data curation, L.S. and A.J.; Formal analysis, L.S. and A.J.; Funding acquisition, E.D.G. and T.W.; Investigation, T.W.; Project administration, E.D.G.; Resources, T.W., K.Z., and A.A.; Supervision, G.G.; Writing—original draft, A.J.; Writing—review and editing, A.J., L.S., T.W., and G.G.

Funding

The work was supported by funding from the Italian Ministry of Health projects IZSAM03/11RC and IZSAM02/17RC. T.W. was partially funded by the Forum for Biopreparedness Diagnostics (FBD), involving four governmental institutes in Sweden: The National Veterinary Institute (SVA), the Public Health Agency of Sweden (FOHM), the National Food Agency (NFA), and the Swedish Defence Research Agency (FOI) financed by the Swedish Civil Contingencies Agency.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Pappas, G.; Papadimitriou, P.; Akritidis, N.; Christou, L.; Tsianos, E.V. The new global map of human brucellosis. Lancet Infect. Dis. 2006, 6, 91–99. [Google Scholar] [CrossRef]
  2. Godfroid, J.; Al Dahouk, S.; Pappas, G.; Roth, F.; Matope, G.; Muma, J.; Marcotty, T.; Pfeiffer, D.; Skjerve, E. A “One Health” surveillance and control of brucellosis in developing countries: Moving away from improvisation. Comp. Immunol. Microbiol. Infect. Dis. 2013, 36, 241–248. [Google Scholar] [CrossRef] [PubMed]
  3. Whatmore, A.M. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infect. Genet. Evol. 2009, 9, 1168–1184. [Google Scholar] [CrossRef] [PubMed]
  4. Buzgan, T.; Karahocagil, M.K.; Irmak, H.; Baran, A.I.; Karsen, H.; Evirgen, O.; Akdeniz, H. Clinical manifestations and complications in 1028 cases of brucellosis: A retrospective evaluation and review of the literature. Int. J. Infect. Dis. 2010, 14. [Google Scholar] [CrossRef] [PubMed]
  5. Dadar, M.; Shahali, Y.; Whatmore, A.M. Human brucellosis caused by raw dairy products: A review on the occurrence, major risk factors and prevention. Int. J. Food Microbiol. 2019, 292, 39–47. [Google Scholar] [CrossRef] [PubMed]
  6. Franco, M.P.; Mulder, M.; Gilman, R.H.; Smits, H.L. Human brucellosis. Lancet Infect. Dis. 2007, 7, 775–786. [Google Scholar] [CrossRef]
  7. Young, E.J. An overview of human brucellosis. Clin. Infect. Dis. 1995, 21, 283–290. [Google Scholar] [CrossRef]
  8. European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017. EFSA J. 2018, 16. [Google Scholar] [CrossRef]
  9. Dean, A.S.; Crump, L.; Greter, H.; Schelling, E.; Zinsstag, J. Global Burden of Human Brucellosis: A Systematic Review of Disease Frequency. PLoS Negl. Trop. Dis. 2012, 6. [Google Scholar] [CrossRef]
  10. Rubach, M.P.; Halliday, J.E.B.; Cleaveland, S.; Crump, J.A. Brucellosis in low-income and middle-income countries. Curr. Opin. Infect. Dis. 2013, 26, 404–412. [Google Scholar] [CrossRef] [Green Version]
  11. Al Dahouk, S.; Neubauer, H.; Hensel, A.; Schöneberg, I.; Nöckler, K.; Alpers, K.; Merzenich, H.; Stark, K.; Jansen, A. Changing epidemiology of human brucellosis, Germany, 1962–2005. Emerg. Infect. Dis. 2007, 13, 1895–1900. [Google Scholar] [CrossRef] [PubMed]
  12. Jansen, W.; Linard, C.; Noll, M.; Nöckler, K.; Al Dahouk, S. Brucella-positive raw milk cheese sold on the inner European market: A public health threat due to illegal import? Food Control. 2019, 100, 130–137. [Google Scholar] [CrossRef]
  13. Gwida, M.; Al Dahouk, S.; Melzer, F.; Rösler, U.; Neubauer, H.; Tomaso, H. Brucellosis—Regionally emerging zoonotic disease? Croat. Med. J. 2010, 51, 289–295. [Google Scholar] [CrossRef] [PubMed]
  14. Vergnaud, G.; Hauck, Y.; Christiany, D.; Daoud, B.; Pourcel, C.; Jacques, I.; Cloeckaert, A.; Zygmunt, M.S. Genotypic expansion within the population structure of classical Brucella species revealed by MLVA16 typing of 1404 Brucella isolates from different animal and geographic origins, 1974–2006. Front. Microbiol. 2018, 9. [Google Scholar] [CrossRef]
  15. ECDC. Monitoring the Use of Whole-Genome Sequencing in Infectious Disease Surveillance in Europe. Stockholm, 2018. Available online: https://ecdc.europa.eu/sites/portal/files/documents/monitoring-WGS-infectious-disease-surveillance-in-Europe-2015-2017-updated-Dec-2018.pdf (accessed on 30 May 2019).
  16. Al Dahouk, S.; Flèche, P.L.; Nöckler, K.; Jacques, I.; Grayon, M.; Scholz, H.C.; Tomaso, H.; Vergnaud, G.; Neubauer, H. Evaluation of Brucella MLVA typing for human brucellosis. J. Microbiol. Methods 2007, 69, 137–145. [Google Scholar] [CrossRef]
  17. Tan, K.K.; Tan, Y.C.; Chang, L.Y.; Lee, K.W.; Nore, S.S.; Yee, W.Y.; Mat Isa, M.N.; Jafar, F.L.; Hoh, C.C.; AbuBakar, S. Full genome SNP-based phylogenetic analysis reveals the origin and global spread of Brucella melitensis. BMC Genom. 2015, 16. [Google Scholar] [CrossRef]
  18. Janowicz, A.; De Massis, F.; Ancora, M.; Cammà, C.; Patavino, C.; Battisti, A.; Prior, K.; Harmsen, D.; Scholz, H.; Zilli, K.; et al. Core genome multilocus sequence typing and single nucleotide polymorphism analysis in the epidemiology of brucella melitensis infections. J. Clin. Microbiol. 2018, 56. [Google Scholar] [CrossRef]
  19. Kaden, R.; Ferrari, S.; Alm, E.; Wahab, T. A novel real-time PCR assay for specific detection of Brucella melitensis. BMC Infect. Dis. 2017, 17. [Google Scholar] [CrossRef]
  20. Drevinek, M.; Dresler, J.; Klimentova, J.; Pisa, L.; Hubalek, M. Evaluation of sample preparation methods for MALDI-TOF MS identification of highly dangerous bacteria. Lett. Appl. Microbiol. 2012, 55, 40–46. [Google Scholar] [CrossRef]
  21. Lista, F.; Reubsaet, F.A.G.; De Santis, R.; Parchen, R.R.; De Jong, A.L.; Kieboom, J.; Van Der Laaken, A.L.; Voskamp-Visser, I.A.I.; Fillo, S.; Jansen, H.J.; et al. Reliable identification at the species level of Brucella isolates with MALDI-TOF-MS. BMC Microbiol. 2011, 11. [Google Scholar] [CrossRef]
  22. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef] [PubMed]
  23. Garofolo, G.; Ancora, M.; Di Giannatale, E. MLVA-16 loci panel on Brucella spp. using multiplex PCR and multicolor capillary electrophoresis. J. Microbiol. Methods 2013, 92, 103–107. [Google Scholar] [CrossRef] [PubMed]
  24. Whatmore, A.M.; Perrett, L.L.; MacMillan, A.P. Characterisation of the genetic diversity of Brucella by multilocus sequencing. BMC Microbiol. 2007, 7. [Google Scholar] [CrossRef] [PubMed]
  25. Nascimento, M.; Sousa, A.; Ramirez, M.; Francisco, A.P.; Carriço, J.A.; Vaz, C. PHYLOViZ 2.0: Providing scalable data integration and visualization for multiple phylogenetic inference methods. Bioinformatics 2017, 33, 128–129. [Google Scholar] [CrossRef] [PubMed]
  26. Georgi, E.; Walter, M.C.; Pfalzgraf, M.T.; Northoff, B.H.; Holdt, L.M.; Scholz, H.C.; Zoeller, L.; Zange, S.; Antwerpen, M.H. Whole genome sequencing of Brucella melitensis isolated from 57 patients in Germany reveals high diversity in strains from Middle East. PLoS ONE 2017, 12. [Google Scholar] [CrossRef] [PubMed]
  27. Hanot Mambres, D.; Boarbi, S.; Michel, P.; Bouker, N.; Escobar-Calle, L.; Desqueper, D.; Fancello, T.; Van Esbroeck, M.; Godfroid, J.; Fretin, D.; et al. Imported human brucellosis in Belgium: Bio and molecular typing of bacterial isolates, 1996–2015. PLoS ONE 2017, 12. [Google Scholar] [CrossRef]
  28. Johansen, T.B.; Scheffer, L.; Jensen, V.K.; Bohlin, J.; Feruglio, S.L. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective. Sci. Rep. 2018, 8. [Google Scholar] [CrossRef]
  29. Refai, M. Incidence and control of brucellosis in the Near East region. Vet. Microbiol. 2002, 90, 81–110. [Google Scholar] [CrossRef]
  30. Musallam, I.I.; Abo-Shehada, M.N.; Hegazy, Y.M.; Holt, H.R.; Guitian, F.J. Systematic review of brucellosis in the Middle East: Disease frequency in ruminants and humans and risk factors for human infection. Epidemiol. Infect. 2016, 144, 671–685. [Google Scholar] [CrossRef]
  31. Gwida, M.; Neubauer, H.; Ilhan, Z.; Schmoock, G.; Melzer, F.; Nöckler, K.; Janczyk, P.; Tomaso, H.; Rösler, U.; Al Dahouk, S. Cross-border molecular tracing of brucellosis in Europe. Comp. Immunol. Microbiol. Infect. Dis. 2012, 35. [Google Scholar] [CrossRef]
  32. Chawjiraphan, W.; Sonthayanon, P.; Chanket, P.; Benjathummarak, S.; Kerdsin, A.; Kalambhaheti, T. Multilocus sequence typing of brucella isolates from Thailand. Southeast. Asian J. Trop. Med. Public Health 2016, 47, 1270–1287. [Google Scholar] [PubMed]
  33. Piao, D.R.; Liu, X.; Di, D.D.; Xiao, P.; Zhao, Z.Z.; Xu, L.Q.; Tian, G.Z.; Zhao, H.Y.; Fan, W.X.; Cui, B.Y.; et al. Genetic polymorphisms identify in species/biovars of Brucella isolated in China between 1953 and 2013 by MLST. BMC Microbiol. 2018, 18. [Google Scholar] [CrossRef] [PubMed]
  34. Whatmore, A.M.; Koylass, M.S.; Muchowski, J.; Edwards-Smallbone, J.; Gopaul, K.K.; Perrett, L.L. Extended multilocus sequence analysis to describe the global population structure of the genus Brucella: Phylogeography and relationship to biovars. Front. Microbiol. 2016, 7. [Google Scholar] [CrossRef] [PubMed]
  35. Alhamada, A.G.; Habib, I.; Barnes, A.; Robertson, I. Risk factors associated with Brucella seropositivity in sheep and goats in Duhok Province, Iraq. Vet. Sci. 2017, 4, 65. [Google Scholar] [CrossRef] [PubMed]
  36. Spink, W.W.; Hall, J.W.; Finstad, J.; Mallet, E. Immunization with viable Brucella organisms. Results of a safety test in humans. Bull. World Health Organ. 1962, 26, 409–419. [Google Scholar] [PubMed]
  37. Higgins, J.L.; Gonzalez-Juarrero, M.; Bowen, R.A. Evaluation of shedding, tissue burdens, and humoral immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence vaccine strain Rev. 1. PLoS ONE 2017, 12. [Google Scholar] [CrossRef] [PubMed]
  38. Garofolo, G.; Fasanella, A.; Di Giannatale, E.; Platone, I.; Sacchini, L.; Persiani, T.; Boskani, T.; Rizzardi, K.; Wahab, T. Cases of human brucellosis in Sweden linked to Middle East and Africa. BMC Res. Notes 2016, 9. [Google Scholar] [CrossRef] [PubMed]
  39. Muñoz, P.M.; Mick, V.; Sacchini, L.; Janowicz, A.; de Miguel, M.J.; Cherfa, M.A.; Nevado, C.R.; Girault, G.; Andrés-Barranco, S.; Jay, M.; et al. Phylogeography and epidemiology of Brucella suis biovar 2 in wildlife and domestic swine. Vet. Microbiol. 2019, 233, 68–77. [Google Scholar] [CrossRef]
Figure 1. Minimum spanning tree of B. melitensis isolates typed by multilocus sequence typing (MLST-9). Published MLST-9 profiles (n = 179) downloaded from the PubMLST Database (https://pubmlst.org/brucella/) and profiles of the strains from this study (n = 103) were used to generate the tree using the goeBURST algorithm in PHYLOViZ software. Each node corresponds to a sequence type (ST), and the branches are labeled with the number of discriminating loci. Swedish isolates obtained from patients with unknown travel history are represented in red.
Figure 1. Minimum spanning tree of B. melitensis isolates typed by multilocus sequence typing (MLST-9). Published MLST-9 profiles (n = 179) downloaded from the PubMLST Database (https://pubmlst.org/brucella/) and profiles of the strains from this study (n = 103) were used to generate the tree using the goeBURST algorithm in PHYLOViZ software. Each node corresponds to a sequence type (ST), and the branches are labeled with the number of discriminating loci. Swedish isolates obtained from patients with unknown travel history are represented in red.
Microorganisms 07 00398 g001
Figure 2. Minimum spanning tree (MST) based on B. melitensis MLVA-8 typing results. The tree was generated using 2535 publicly available MLVA profiles and 103 profiles of Swedish isolates calculated in silico. The nodes are labeled with the genotype and colored according to genetic lineage. MLVA-8 types obtained from strains characterized in this study are shown in gray.
Figure 2. Minimum spanning tree (MST) based on B. melitensis MLVA-8 typing results. The tree was generated using 2535 publicly available MLVA profiles and 103 profiles of Swedish isolates calculated in silico. The nodes are labeled with the genotype and colored according to genetic lineage. MLVA-8 types obtained from strains characterized in this study are shown in gray.
Microorganisms 07 00398 g002
Figure 3. Minimum spanning tree (MST) generated for 242 isolates of B. melitensis using the gene-by-gene approach. MST was calculated by pairwise comparison of 2704 target genes with missing values ignored. Nodes correspond to unique profiles and are colored according to the published country of isolation and the branches correspond to the number of discriminating loci. Strains obtained from patients in Sweden are depicted in red and B. melitensis vaccine strain Rev.1 is shown in black. Complexes of genotypes within a distance of six alleles are highlighted in gray.
Figure 3. Minimum spanning tree (MST) generated for 242 isolates of B. melitensis using the gene-by-gene approach. MST was calculated by pairwise comparison of 2704 target genes with missing values ignored. Nodes correspond to unique profiles and are colored according to the published country of isolation and the branches correspond to the number of discriminating loci. Strains obtained from patients in Sweden are depicted in red and B. melitensis vaccine strain Rev.1 is shown in black. Complexes of genotypes within a distance of six alleles are highlighted in gray.
Microorganisms 07 00398 g003
Table 1. B. melitensis isolates analyzed in this study.
Table 1. B. melitensis isolates analyzed in this study.
Sample IDBVSTYearCountryPutative Origin (MLVA-16)MLVA-16 DistanceVNTRs Recovered
MLVA-16
Putative Origin (WGS)Core Genome DistancecgMLST Complex
2017-TE-24378-1-13111994NAFrance216USA115
2017-TE-24378-1-2381994NAChina216Somalia64
2017-TE-24378-1-33121995NATurkey/China616Somalia127
2017-TE-24378-1-4281995NAIraq016Afghanistan20
2017-TE-24378-1-5171995NAPeru415Argentina164
2017-TE-24378-1-63121996NATurkey/China416Somalia157C6
2017-TE-24378-1-73121996NATurkey/China416Somalia156C6
2017-TE-24378-1-83121996NATurkey/China416Somalia157C6
2017-TE-24378-1-93121996NATurkey/China416Somalia156C6
2017-TE-24378-1-10381997NASaudi Arabia/China/
Turkey/Belgium
315Syria9
2017-TE-24378-1-11171998NAGermany414Malta58
2017-TE-24378-1-12381998NAChina315Iraq5C2
2017-TE-24378-1-13382000NAChina116Kosovo26
2017-TE-24378-1-14382001NAChina216Syria9
2017-TE-24378-1-15282002NASpain116Portugal22
2017-TE-24378-1-17382002NAChina116Syria12
2017-TE-24378-1-19382002NASaudi Arabia/China/
Turkey/Belgium
116Syria8
2017-TE-24378-1-20382003NAIraq016Syria6C9
2017-TE-24378-1-21382003NASaudi Arabia/China/
Turkey/Belgium
116Syria9
2017-TE-24378-1-22382004NAChina116Syria11
2017-TE-24378-1-23382004SyriaSouth Africa415Turkey97
2017-TE-24378-1-24382004IraqChina215Turkey8
2017-TE-24378-1-253122005EthiopiaSomalia513Somalia2C7
2017-TE-24378-1-26382005NAChina215Syria/Iraq16C3
2017-TE-24378-1-27382005NAIndia/
Turkmenistan/
China
315Turkey14C15
2017-TE-24378-1-28382005NAIndia/China116Turkey10C8
2017-TE-24378-1-293122005SomaliaTurkey/China716Somalia161
2017-TE-24378-1-30382005NAKazakhstan/China116Iraq28
2017-TE-24378-1-31382005IraqChina116Syria11
2017-TE-24378-1-323122008NASpain515Ethiopia36
2017-TE-24378-1-33382006NAChina315Iraq21
2017-TE-24378-1-34382006NAChina116Turkey9
2017-TE-24378-1-35382006SyriaIndia/
Turkmenistan/
China
216Syria/
Turkey
23
2017-TE-24378-1-36382006NAIndia116Turkey8
2017-TE-24378-1-37282007NASaudi Arabia/China/
Turkey/Belgium
316India73
2017-TE-24378-1-38382007NASaudi Arabia/China/
Turkey/Belgium
116Syria11C17
2017-TE-24378-1-39382007SyriaSaudi Arabia/China/
Turkey/Belgium
116Syria11C17
2017-TE-24378-1-40382007NASaudi Arabia/China/
Turkey/Belgium
116Syria11C17
2017-TE-24378-1-41282007IraqChina116Syria24
2017-TE-24378-1-42382007SyriaChina215Turkey11
2017-TE-24378-1-43382008NAIndia/
Turkmenistan/
China
216Turkey14C15
2017-TE-24378-1-45382008NAChina216Iraq16
2017-TE-24378-1-46382008NAChina216Iraq32
2017-TE-24378-1-47382009IraqChina116Syria/Iraq9
2017-TE-24378-1-483122009NASpain916Somalia101
2017-TE-24378-1-49382009NAChina116Turkey12
2017-TE-24378-1-50382009IraqSaudi Arabia/China/
Turkey/Belgium
116Syria/Iraq17C3
2017-TE-24378-1-51382010NAIndia/
Turkmenistan/
China
314Turkey7C4
2017-TE-24378-1-52382010NAChina415Somalia38
2017-TE-24378-1-53382011NASaudi Arabia/China/
Turkey/Belgium
116Syria/Iraq20C3
2017-TE-24378-1-54382011SyriaChina316Iraq23
2017-TE-24378-1-55382011SwedenChina316Iraq24
2017-TE-24378-1-56282011IndiaIndia/China116India38
2017-TE-24378-1-57382011NAChina215Iraq5C2
2017-TE-24378-1-58382011IraqSaudi Arabia/China/
Turkey/Belgium
215Syria, Iraq17C3
2017-TE-24378-1-59382011NASaudi Arabia/China/
Turkey/Belgium
116Syria/Iraq17C3
2017-TE-24378-1-60382011NAChina215Iraq21
2017-TE-24378-1-62282011NAChina316Georgia33
2017-TE-24378-1-63382012NAKazakhstan/
China
116Syria14
2017-TE-24378-1-64382012NAChina215Iraq7
2017-TE-24378-1-65382012IraqChina115Turkey13
2017-TE-24378-1-66382012NAKazakhstan/China215Iraq29
2017-TE-24378-1-67382012NAChina214Turkey13
2017-TE-24378-1-68382012NAKazakhstan/
China/Mongolia
315Afghanistan32
2017-TE-24378-1-693122012NASpain815Somalia1C12
2017-TE-24378-1-70282012TurkeyChina215Syria/Turkey24
2017-TE-24378-1-71382012LebanonKazakhstan/
China
315Turkey15
2017-TE-24378-1-72382012IraqIndia/
Turkmenistan/
China
116Syria20
2017-TE-24378-1-73382013NAIndia/
Turkmenistan/
China
215Syria20
2017-TE-24378-1-74382013IraqIndia/
Turkmenistan/
China
316Turkey15C15
2017-TE-24378-1-75382013NASaudi Arabia/China/
Turkey/Belgium
116Syria/Iraq19C3
2017-TE-24378-1-76282013NATurkey415Afghanistan37
2017-TE-24378-1-77382013TurkeyChina315Syria/
Turkey
28
2017-TE-24378-1-78282013NAChina216Syria/
Turkey
28
2017-TE-24378-1-793122014NASpain814Somalia0
2017-TE-24378-1-803122014NASpain714Somalia64
2017-TE-24378-1-812712014NATurkey/Iran/Iraq/
Jordan
215Turkmenistan78
2017-TE-24378-1-82282014NATurkey316Afghanistan37
2017-TE-24378-1-83382014NAChina316Turkey1C4
2017-TE-24378-1-84382014NAIndia/
Turkmenistan/
China
116United Kingdom17
2017-TE-24378-1-85382014NAIndia/
Turkmenistan/
China
415Turkey2C11
2017-TE-24378-1-86382014SyriaIndia/
Turkmenistan/
China
415Turkey2C11
2017-TE-24378-1-87382014SyriaIndia/
Turkmenistan/
China
215Turkey2C11
2017-TE-24378-1-88382014NAIndia/
Turkmenistan/
China
315Turkey2C11
2017-TE-24378-1-89382014NAChina315Turkey0C4
2017-TE-24378-1-90172014IraqIsrael/Portugal/
France/Italy
316Argentina164
2017-TE-24378-1-91382014IraqChina216Turkey1C4
2017-TE-24378-1-92382015IraqChina315Turkey9C8
2017-TE-24378-1-93382015IraqChina216Turkey8C8
2017-TE-24378-1-94382015IraqSaudi Arabia/China/
Turkey/Belgium
315Iraq2C2
2017-TE-24378-1-953112015EritreaTunisia/France315Morocco29
2017-TE-24378-1-96382015IraqChina/India215Turkey12
2017-TE-24378-1-97382015NAChina216Syria13
2017-TE-24378-1-98282015SyriaSaudi Arabia/China/
Turkey/Belgium
116Turkey/ Kuwait76
2017-TE-24378-1-99382015NAChina116Syria14
2017-TE-24378-1-100382015SyriaChina/India116Turkey4
2017-TE-24378-1-101382015NAChina/India116Iraq3C2
2017-TE-24378-1-102382016NASaudi Arabia/China/
Turkey/Belgium
415Turkey10
2017-TE-24378-1-1033122016NASpain416Ethiopia36
2017-TE-24378-1-104382001NAChina215Turkey9
2017-TE-24378-1-1052712010NAIraq115Turkmenistan73
2017-TE-24378-1-108282011NAChina116Syria25
2017-TE-24378-1-109282011NAChina316Georgia33
BV: Biovar; NA: Not available, ST: Sequence Type.

Share and Cite

MDPI and ACS Style

Sacchini, L.; Wahab, T.; Di Giannatale, E.; Zilli, K.; Abass, A.; Garofolo, G.; Janowicz, A. Whole Genome Sequencing for Tracing Geographical Origin of Imported Cases of Human Brucellosis in Sweden. Microorganisms 2019, 7, 398. https://doi.org/10.3390/microorganisms7100398

AMA Style

Sacchini L, Wahab T, Di Giannatale E, Zilli K, Abass A, Garofolo G, Janowicz A. Whole Genome Sequencing for Tracing Geographical Origin of Imported Cases of Human Brucellosis in Sweden. Microorganisms. 2019; 7(10):398. https://doi.org/10.3390/microorganisms7100398

Chicago/Turabian Style

Sacchini, Lorena, Tara Wahab, Elisabetta Di Giannatale, Katiuscia Zilli, Anna Abass, Giuliano Garofolo, and Anna Janowicz. 2019. "Whole Genome Sequencing for Tracing Geographical Origin of Imported Cases of Human Brucellosis in Sweden" Microorganisms 7, no. 10: 398. https://doi.org/10.3390/microorganisms7100398

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop